U.S. markets open in 8 hours 46 minutes
  • S&P Futures

    3,362.00
    -21.00 (-0.62%)
     
  • Dow Futures

    27,189.00
    -176.00 (-0.64%)
     
  • Nasdaq Futures

    11,537.00
    -51.00 (-0.44%)
     
  • Russell 2000 Futures

    1,573.00
    -16.00 (-1.01%)
     
  • Crude Oil

    38.72
    -0.85 (-2.15%)
     
  • Gold

    1,910.10
    -1.80 (-0.09%)
     
  • Silver

    24.45
    -0.11 (-0.47%)
     
  • EUR/USD

    1.1784
    -0.0006 (-0.05%)
     
  • 10-Yr Bond

    0.7780
    -0.7780 (-100.00%)
     
  • Vix

    33.35
    +0.89 (+2.74%)
     
  • GBP/USD

    1.3042
    +0.0001 (+0.01%)
     
  • USD/JPY

    104.2060
    -0.2880 (-0.28%)
     
  • BTC-USD

    13,780.74
    +85.44 (+0.62%)
     
  • CMC Crypto 200

    272.42
    +11.13 (+4.26%)
     
  • FTSE 100

    5,728.99
    -63.02 (-1.09%)
     
  • Nikkei 225

    23,378.23
    -107.57 (-0.46%)
     

STAA DEADLINE: Zhang Investor Law Reminds STAAR Surgical Company Investors of Deadline in Securities Class Action – STAA

Zhang Investor Law P.C.
·1 min read

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of STAAR Surgical Company (NASDAQ: STAA) between February 26, 2020 and August 10, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover investor losses under the federal securities laws.

If you wish to serve as lead plaintiff, you must move the Court before the OCTOBER 19, 2020 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=staar-surgical-company&id=2405 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=staar-surgical-company&id=2405

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and (4) as a result of the foregoing, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
info@zhanginvestorlaw.com
tel: (800) 991-3756